These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 22647192)

  • 21. The reliability of molecular dynamics simulations of the multidrug transporter P-glycoprotein in a membrane environment.
    Condic-Jurkic K; Subramanian N; Mark AE; O'Mara ML
    PLoS One; 2018; 13(1):e0191882. PubMed ID: 29370310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conformational changes of P-glycoprotein by nucleotide binding.
    Wang G; Pincheira R; Zhang M; Zhang JT
    Biochem J; 1997 Dec; 328 ( Pt 3)(Pt 3):897-904. PubMed ID: 9396736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding Site Interactions of Modulators of Breast Cancer Resistance Protein, Multidrug Resistance-Associated Protein 2, and P-Glycoprotein Activity.
    Deng F; Ghemtio L; Grazhdankin E; Wipf P; Xhaard H; Kidron H
    Mol Pharm; 2020 Jul; 17(7):2398-2410. PubMed ID: 32496785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transition state analysis of the coupling of drug transport to ATP hydrolysis by P-glycoprotein.
    Al-Shawi MK; Polar MK; Omote H; Figler RA
    J Biol Chem; 2003 Dec; 278(52):52629-40. PubMed ID: 14551217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the catalytic cycle of ATP hydrolysis by human P-glycoprotein. The two ATP hydrolysis events in a single catalytic cycle are kinetically similar but affect different functional outcomes.
    Sauna ZE; Ambudkar SV
    J Biol Chem; 2001 Apr; 276(15):11653-61. PubMed ID: 11154703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding site of ABC transporter homology models confirmed by ABCB1 crystal structure.
    Ravna AW; Sylte I; Sager G
    Theor Biol Med Model; 2009 Sep; 6():20. PubMed ID: 19732422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conformational analysis of human ATP-binding cassette transporter ABCB1 in lipid nanodiscs and inhibition by the antibodies MRK16 and UIC2.
    Ritchie TK; Kwon H; Atkins WM
    J Biol Chem; 2011 Nov; 286(45):39489-96. PubMed ID: 21937435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure of multidrug-resistance proteins of the ATP-binding cassette (ABC) superfamily.
    Altenberg GA
    Curr Med Chem Anticancer Agents; 2004 Jan; 4(1):53-62. PubMed ID: 14754412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Theoretical insights on helix repacking as the origin of P-glycoprotein promiscuity.
    Bonito CA; Ferreira RJ; Ferreira MU; Gillet JP; Cordeiro MNDS; Dos Santos DJVA
    Sci Rep; 2020 Jun; 10(1):9823. PubMed ID: 32555203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. P-glycoprotein-mediated resistance to chemotherapy in cancer cells: using recombinant cytosolic domains to establish structure-function relationships.
    Di Pietro A; Dayan G; Conseil G; Steinfels E; Krell T; Trompier D; Baubichon-Cortay H; Jault J
    Braz J Med Biol Res; 1999 Aug; 32(8):925-39. PubMed ID: 10454753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dissecting the Forces that Dominate Dimerization of the Nucleotide Binding Domains of ABCB1.
    Szöllősi D; Szakács G; Chiba P; Stockner T
    Biophys J; 2018 Jan; 114(2):331-342. PubMed ID: 29401431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Importance of the conserved Walker B glutamate residues, 556 and 1201, for the completion of the catalytic cycle of ATP hydrolysis by human P-glycoprotein (ABCB1).
    Sauna ZE; Müller M; Peng XH; Ambudkar SV
    Biochemistry; 2002 Nov; 41(47):13989-4000. PubMed ID: 12437356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of two different states of P-glycoprotein in its catalytic cycle: role of the linker region in the transition between these two states.
    Rao US; Nuti SL
    J Biol Chem; 2003 Nov; 278(47):46576-82. PubMed ID: 12968025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crystal structure of the multidrug transporter P-glycoprotein from Caenorhabditis elegans.
    Jin MS; Oldham ML; Zhang Q; Chen J
    Nature; 2012 Oct; 490(7421):566-9. PubMed ID: 23000902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for a Sav1866-like architecture for the human multidrug transporter P-glycoprotein.
    Zolnerciks JK; Wooding C; Linton KJ
    FASEB J; 2007 Dec; 21(14):3937-48. PubMed ID: 17627029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploring the dynamics of the ABCB1 membrane transporter P-glycoprotein in the presence of ATP and active/non-active compounds through molecular dynamics simulations.
    Mora Lagares L; Pérez-Castillo Y; Novič M
    Toxicology; 2024 Feb; 502():153732. PubMed ID: 38272384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug-Induced Conformational Dynamics of P-Glycoprotein Underlies the Transport of Camptothecin Analogs.
    Mensah GAK; Schaefer KG; Bartlett MG; Roberts AG; King GM
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism of ABC transporters: a molecular dynamics simulation of a well characterized nucleotide-binding subunit.
    Jones PM; George AM
    Proc Natl Acad Sci U S A; 2002 Oct; 99(20):12639-44. PubMed ID: 12237398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Q loops of the human multidrug resistance transporter ABCB1 are necessary to couple drug binding to the ATP catalytic cycle.
    Zolnerciks JK; Akkaya BG; Snippe M; Chiba P; Seelig A; Linton KJ
    FASEB J; 2014 Oct; 28(10):4335-46. PubMed ID: 25016028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of MDR1 P-glycoprotein conformational changes in permeabilized cells using differential immunoreactivity.
    Druley TE; Stein WD; Roninson IB
    Biochemistry; 2001 Apr; 40(14):4312-22. PubMed ID: 11284687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.